# Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance

> **NCT00137657** · PHASE4 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 1478 (—)

## Conditions studied

- HIV
- Malaria
- Diarrhea
- Pneumonia
- Opportunistic Infections

## Interventions

- **DRUG:** Cotrimoxazole (trimethoprim sulfamethoxazole)

## Key facts

- **NCT ID:** NCT00137657
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2003-11
- **Target enrollment:** 1478 (—)
- **Last updated:** 2005-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137657, "Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00137657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*